Submucosal bioresorbable drug eluting platform
US12403291B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Aug 27, 2020 |
| Grant date | Sep 2, 2025 |
| Priority date | — |
| Expiry date | Feb 19, 2044 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2210/105
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Systems and methods for delivering a therapeutic agent to target tissue using a plurality of drug delivery platforms each having a polymer scaffold and the therapeutic agent contained within the polymer scaffold. Each drug delivery platform of the plurality of drug delivery platforms is implanted into the target tissue, allowing the therapeutic agent to elute from each drug delivery platform of the plurality of drug delivery platforms for a target period of time, delivering a therapeutic dose of the therapeutic agent for the target period of time. Each drug delivery platform of the plurality of drug delivery platforms is allowed to biodegrade within the target tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.